Diagnosis of a 9-month-old boy brought to our genetics clinic with chief complaints of developmental delay (DD), failure to thrive, microcephaly, trunk hypotonia and hypertonia of the extremities. Multiple congenital defects but no significant syndromes or diseases were impressed. The chromosomal analysis and array comparative genomic hybridization (aCGH) revealed no significant pathogenic changes. Whole Genome Sequencing (WGS) identified a p.Glu1139fs mutation of the gene. The patient's phenotype was consistent clinically with Arboleda-Tham syndrome (ARTHS). Reviewing the literature showed that this is the first patient in Taiwan detected by WGS and that it involves a novel mutation. Comparing the highly variable clinical presentations of this syndrome with our patient, this boy's features and severe developmental defects seem to be due to a late-truncating mutation at the carboxyl end of the KAT6A protein. Our study demonstrates the power of WGS to confirm a diagnosis within 4 weeks for this rare condition.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7723794PMC
http://dx.doi.org/10.1016/j.ymgmr.2020.100686DOI Listing

Publication Analysis

Top Keywords

arboleda-tham syndrome
8
genome sequencing
8
severe developmental
8
developmental delay
8
diagnosis arboleda-tham
4
syndrome genome
4
sequencing asian
4
asian boy
4
boy severe
4
delay diagnosis
4

Similar Publications

Phenotypic variability in a family with an inherited KAT6A frameshift variant.

Eur J Med Genet

December 2024

Department of Clinical Genetics, Aarhus University Hospital, Aarhus, Denmark; Centre for Rare Diseases, Pediatrics and Adolescent Medicine, Aarhus University Hospital, Aarhus, Denmark; Department of Clinical Medicine, Aarhus University, Denmark.

KAT6A syndrome or Arboleda-Tham Syndrome (ARTHS; OMIM #616268) is a syndromic neurodevelopmental disorder mainly presenting with variable degrees of intellectual disability (ID) and developmental delay (DD), especially speech delay, hypotonia and autism spectrum disorders/behavioral problems. Multiple organ-systems including eyes, heart, gastrointestinal and neurological system can be involved. Other phenotypic features with a suggested association to KAT6A include immune dysfunction and pituitary anomalies.

View Article and Find Full Text PDF

Objective: This study aims to report a severe phenotype of Arboleda-Tham syndrome in a 20-month-old girl, characterized by global developmental delay, distinct facial features, intellectual disability. Arboleda-Tham syndrome is known for its wide phenotypic spectrum and is associated with truncating variants in the KAT6A gene.

Methods: To diagnose this case, a combination of clinical phenotype assessment and whole-exome sequencing technology was employed.

View Article and Find Full Text PDF

Background: KAT6A (Arboleda-Tham) syndrome is a Mendelian disorder of the epigenetic machinery caused by pathogenic variants in the lysine acetyltransferase 6 A (KAT6A) gene. Intellectual disability and speech/language impairment (e.g.

View Article and Find Full Text PDF

Arboleda-Tham syndrome (ARTHS, MIM 616268) is a rare genetic disease, due to a pathogenic variant of Lysine (K) Acetyltransferase 6A (KAT6A) with autosomal dominant inheritance. Firstly described in 2015, ARTHS is one of the more common causes of undiagnosed syndromic intellectual disability. Due to extreme phenotypic variability, ARTHS clinical diagnosis is challenging, mostly at early stage of the disease.

View Article and Find Full Text PDF

KAT6A mutations in Arboleda-Tham syndrome drive epigenetic regulation of posterior HOXC cluster.

Hum Genet

December 2023

Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, UCLA, 615 Charles E. Young Drive South, Los Angeles, CA, 90095, USA.

Article Synopsis
  • - Arboleda-Tham Syndrome (ARTHS) is a rare genetic disorder linked to mutations in the KAT6A gene, resulting in symptoms like intellectual disability, developmental delays, and hypotonia, affecting multiple organs.
  • - The study analyzed dermal fibroblasts from ARTHS patients and controls, revealing that about 23% of genes showed different chromatin accessibility and expression, particularly in genes from the HOXC gene cluster, which are vital for early developmental processes.
  • - Additionally, researchers discovered two new disrupted histone modifications (H2A and H3K56 acetylation) in ARTHS, highlighting the complex regulatory roles of KAT6A on gene expression and epigenomic changes
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!